Jump to content

Search the Community

Showing results for tags 'Measles'.



More search options

  • Search By Tags

    Type tags separated by commas.
  • Search By Author

Content Type


Forums

  • Discussions
    • European Immunization Week, 23–29 April 2018
    • Flu awareness
    • Migration and immunization
    • World Hepatitis Day, 28 July 2017
    • European Immunization Week, 24 - 30 April 2017
    • General discussions
    • Education on Immunization
    • Data visualization
    • Polio
    • About NITAGs
    • Research papers, articles, and reports
    • News and social media
    • Updates from partners and stakeholders
    • European Immunization Week (2016)
    • Job opportunities
    • Q&A about the site
    • Innsbruck Treffen (private forum)

Categories

  • European Immunization Week 2018
    • Planning resources - EIW 2018
    • Brochures - EIW 2018
    • Infographics - EIW 2018
    • Posters - EIW 2018
    • Banners and social media - EIW 2018
    • Meeting folders - EIW 2018
  • Flu Awareness - 2017
    • Flu Awareness Campaign Posters
  • European Immunization Week 2017
    • Planning resources - EIW 2017
    • Brochures - EIW 2017
    • Infographics - EIW 2017
    • Posters - EIW 2017
    • Banners and social media - EIW 2017
    • Meeting folders - EIW 2017
  • Flu Awareness - 2016
    • Flu Awareness Campaign Posters
  • EIW 2016
    • Planning resources
    • Posters
    • Meeting folders

Find results in...

Find results that contain...


Date Created

  • Start

    End


Last Updated

  • Start

    End


Filter by number of...

Joined

  • Start

    End


Group


About Me


Gender


Location


Country

Found 43 results

  1. On 27th of April working meeting on Measles was conducted with participation of over 50 staff of NCDC, WHO, UNICEF, CDC, regional public health specials and pediatricians to discuss issues on the below mentioned topics: - Measles and Rubella Global and Regional Epidemiological Overview - Analysis of Measles outbreak in Georgia - Immunization Coverage Survey results and recommendations - Results and recommendations of two KAP surveys on immunization conducted among parents (UNICEF funded) and Adults (CDC/WHO funded) - Immunization Management Module challenges and achievements - Responses to current measles outbreak - Measles and Rubella Elimination Plan
  2. Immunize Europe Forum

    Azerbaijani: EIW 2018 materials

    Version 1.0.0

    12 downloads

    Azerbaijani: EIW 2018 materials
  3. Dear Colleagues We would like to share with you the following graphics from ECDC in support of European Immunization Week (EIW). ECDC measles infographic with updated data from 2017 PowerPoint slides with key messages on catch-up vaccination The slides can be easily translated and we are happy for you to re-use if you find the material useful. Rumila Edward and Sarah Earnshaw ECDC Measles messages.pptx Measles_2018.pdf
  4. Immunize Europe Forum

    Kopb

    Version 1.0.0

    6 downloads

    EIW 2018
  5. Measles cases increase significantly in the last month in a number of EU/EEA countries Measles cases continue to increase in a number of EU/EEA countries. The highest number of cases to date in 2018 were in Romania (1 709), Greece (1 463) France (1 346) and Italy (411) respectively. Thirteen deaths have also been reported by these countries in 2018. Although cases in Romania and Greece remain high, of particular concern is the situation in France and Italy, with cases almost tripling in France since the previous update in March, and more than doubling in Italy. This is according to the most recent measles data collected by ECDC through epidemic intelligence and published in the Communicable Diseases Threats Report (CDTR) today. In the 12-month period between 1 March 2017 and 28 February 2018, 14 813 cases of measles were reported to ECDC through the European Surveillance System which is detailed in ECDC’s monthly measles and rubella monitoring report also published today. Of these cases where age was known, 35% were in children under five and 47% were in those 15 and older. Where vaccination status was known, 86% were unvaccinated. In order to reach elimination and protect those most vulnerable to severe complications and death from measles such as infants, 95% of the population needs to be vaccinated with two doses of measles-containing vaccine. Vaccination coverage was below 95% in 22 out of 29 EU/EEA countries for the second dose of a measles-containing vaccine according to the most recent data collected (WHO 2016), showing that further sustained action is needed. The data further showed the high proportion of cases among young adults who may have missed vaccination, highlighting the need for them to check their vaccination status and get vaccinated if needed. Read more The following outputs are available for a complete overview of data regarding measles outbreaks in the EU/EEA Communicable Disease Threat Report - “Measles and Rubella, Monitoring European and worldwide outbreaks” - Epidemic intelligence data Monthly measles and rubella monitoring report - European Surveillance System data (TESSy) Rapid risk assessment: risk of measles transmission in the EU/EEA – TESSy and epidemic intelligence data Bi-annual measles and rubella monitoring report -TESSy and epidemic intelligence data ECDC Atlas of Infectious Diseases -TESSy data ECDC vaccine scheduler
  6. Immunize Europe Forum

    Measles

    Version 1.0.0

    49 downloads

    EIW 2018 Infographics Measles English in PDF (green download button on the right) or in editable AI format (Adobe Illustrator) here: Measles_EIW_2018_WHO_FINAL.ai
  7. Immunize Europe Forum

    Measles

    Measles
  8. Measles outbreaks continue to occur in a number of EU/EEA countries, and there is a risk of spread and sustained transmission in areas with susceptible populations. Since the beginning of 2016, 48 deaths due to measles were reported in the EU. New data published today by ECDC in the Communicable Disease Threat Report (CDTR) show that the highest number of measles cases in 2017 were reported in Romania (7 977), Italy (4 854) and Germany (904). Greece is currently experiencing a measles outbreak, with 690 cases including two deaths, reported since May 2017; most cases were unvaccinated or incompletely vaccinated. The monthly measles and rubella surveillance monitoring report is also published today and provides more in-depth analysis of the situation. The spread of measles across Europe is due to suboptimal vaccination coverage in many EU/EEA countries: of all measles cases reported during the one-year period 1 November 2016‒31 October 2017 with known vaccination status, 87% were not vaccinated. Measles increasingly affects all age groups across Europe and in 2017, 45% of measles cases with known age were aged 15 years or older. Romania, Italy, Germany and Greece were the countries most affected by measles during 2016 and 2017 and each shows different trends: Romania saw a sharp increase in cases from October 2016, and the trend has continued throughout 2017; in Italy, the increasing trend started in January 2017, while in Germany it began in February 2017; Greece has seen a measles outbreak starting in the second half of 2017, with 167 cases reported in October. This data is based on analysis of the cases notified to ECDC and included in the monthly and biannual monitoring reports. The latest available figures on vaccination coverage collected by WHO (2016) show that the vaccination coverage for the first dose of measles was below 95% in 18 of 30 EU/EEA countries; for the second dose of measles, it was below 95% in 20 of 27 EU/EEA countries reporting second dose coverage data. In order to achieve the measles elimination goal, the vaccination coverage rates for children targeted by routine vaccination programmes should increase in a number of countries, as the vaccination coverage of the second dose must be at least 95% to interrupt measles circulation and achieve herd immunity. This is particularly important to protect children below one year of age, who are particularly vulnerable to complications of measles but are too young to have received the first dose of vaccine. Read more ECDC collects measles data on a monthly basis via The European Surveillance System (TESSy). In addition, ECDC monitors measles and rubella epidemiology and outbreaks via epidemic intelligence. For a complete overview of data regarding measles outbreaks in the EU/EEA in 2016 and 2017, the following outputs are available and regularly updated: Communicable Disease Threat Report “Measles and Rubella, Monitoring European and worldwide outbreaks” (Epidemic intelligence data) Monthly measles and rubella monitoring report (a concise report with TESSy data from 1 November 2016 – 31 October 2017) Bi-annual measles and rubella monitoring report (an extensive report, TESSy and epidemic intelligence data presented, with data from 1 January 2016 – 30 June 2017) ECDC Atlas of Infectious Diseases (TESSy data) Monthly-Measles-Rubella-monitoring-report-December-2017_0.pdf
  9. Press release Copenhagen, 26 September 2017 In the WHO European Region, 42 of 53 countries have interrupted endemic transmission of measles, and 37 countries have interrupted endemic transmission of rubella as of the end of 2016. This was determined by the European Regional Verification Commission for Measles and Rubella Elimination (RVC) at its 6th meeting in June 2017. Full press release
  10. WHO/Europe is looking for qualified experts interested in playing a key role in measles and rubella elimination as (volunteer) members of the RVC. The application deadline is 30 September 2017. http://www.euro.who.int/en/about-us/jobs-and-internships/short-term-opportunities/call-for-expressions-of-interest-in-serving-as-member-of-the-european-regional-verification-commission-for-measles-and-rubella-elimination-rvc
  11. Ukraine is among only 14 countries in the WHO European Region where measles and rubella remain endemic. With WHO support, a national conference on measles and rubella elimination held on 21–22 February 2017 in Kyiv.
  12. Immunize Europe Forum

    EIW 2017 Germany - Measles videos

    Videos explaining the measles vaccination recommendations for children and adults. http://www.impfen-info.de/mediathek/filme/

    © Federal Centre for Health Education - Germany

  13. Immunize Europe Forum

    EIW 2017 Germany - VacMap

    The tool shows age specific measles vaccination rates for each administrative district in Germany. www.vacmap.de

    © Robert Koch Institut

  14. In accordance with its mandate to provide guidance to the Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes. They summarize essential background information on vaccine preventable diseases and vaccines and conclude with the current WHO position on the use of vaccines worldwide. Full text at WHO Bulletin 28 April 2017
  15. Today ECDC published the latest surveillance data on measles. This data covers 1 April 2016 - 31 March 2017. Of all cases with known age (n=5 876), 2 426 (41%) were children less than 5 years of age, while 2 208 (38%) were aged 15 years or over. This reiterates the importance of vaccination throughout life and that measles affects all age groups. Many adults do not realise that they are susceptible to vaccine preventable diseases. They may not have had access to currently available vaccines as a child, nor developed immunity to the diseases through natural infection. Between 1 April 2016 and 31 March 2017, 30 EU/EEA Member States reported 6 597 cases of measles. In the 12-month period, the highest number of cases was reported by Romania (3 072), Italy (1 314) and Germany (711), accounting respectively for 47%, 20% and 11% of the EU/EEA cases. In the first three months of 2017, a total of 2 480 cases were observed; in comparison, a total of 530 cases were reported in the first three months in 2016. In the first three months of 2017 the countries contributing to the majority of cases were Romania (749), Italy (684) and Germany (411). Read the full report here
  16. until
    ECDC's Lucia Pastore Celentano, Head of the Vaccine Preventable Disease program will present on "Recent epidemiology and outbreaks of measles in Europe" at the ECCMID conference in Vienna. LuciaPC_ECCMID_240417_measles_final.pptx
  17. Measles does not only affect children: trends for 2016 and outbreaks in Europe during 2017 During the first 2 months of 2017 we have seen 1524 cases of measles reported from 14 EU/EEA countries. Measles does not only affect children but also older age groups. In 2014 over half of the cases were in adults over 20 years old, in 2015 and 2016 this age group accounted for approximately one third of all cases. Closing immunisation gaps in adolescents and adults who have not received vaccination in the past as well as strengthening routine childhood immunisation programmes will be vital to prevent future outbreaks and reach the elimination goal. The only way to prevent illness, disability and death from vaccine preventable diseases is through timely and complete vaccination according to each country’s national immunization schedule. ECDC joins the European Immunization Week initiative to increase awareness of the importance of immunisation throughout life and thereby help build and sustain immunity in all communities throughout the European Region. ECDC Acting Director Dr Andrea Ammon said “It is worrying to see accumulation of unvaccinated individuals and as a consequence outbreaks of measles in several European countries in recent months.” Ammon continues “A further challenge in reaching the elimination goal in Europe is the high proportion of cases observed in older age groups. In 2016 28% of measles cases were above 20 years old. ” Many adults do not realize that they are susceptible to vaccine preventable diseases. They may not have had access to currently available vaccines as a child, nor developed immunity to the diseases through natural infection. The age group accounting for the largest proportion of measles cases in both 2014 and 2015 was the over 20 year olds (53% in 2014, 38% in 2015). This highlights the importance of closing immunisation gaps in adolescents and adults who have not received vaccination in the past. "It is inacceptable to hear that children and adults are dying from disease where safe and cost-effective vaccines are available. Though vaccine coverage remains relatively high in the EU, we need to continue our efforts to raise awareness and acceptance of vaccination", says Vytenis Andriukaitis, European Commissioner for Health and Food Safety. "The Commission is committed to stepping up EU support for national immunisation strategies. Improving access to vaccines, addressing vaccine shortages, countering vaccine hesitancy, facilitating comprehensive vaccination programmes and strengthening research and development are among our priorities." In the last twelve months, between 1 March 2016 and 28 February 2017, 5 881 cases of measles were reported by 30 EU/EEA countries; Romania accounted for 46% of all cases reported in this period. Other countries with a high proportion of cases were Italy (24 %), the United Kingdom (9%). A measles outbreak is ongoing in Romania and cases continue to be reported despite response measures that have been implemented at national level through reinforced vaccination activities. Since 1 January 2016 and as of 7 April 2017 a total of 4 090 cases were reported. In 2016, a number of other EU/EEA countries reported measles outbreaks, and an increase in the number of cases continues to be observed in 2017. In 10 countries (Austria, Belgium, Croatia, France, Germany, Italy, Poland, Romania, Spain and Sweden) the number of cases reported in January-February 2017 was more than double compared to the same period in 2016. Despite the progress towards measles elimination reported by The Regional Verification Commission for Measles and Rubella Elimination the vaccination coverage is still sub-optimal in many EU/EEA countries. Interrupting transmission requires at least 95% vaccination coverage with two doses in every district and community. The latest available data (2015) shows that the vaccination coverage for the second dose of measles was below 95% in 15 of 23 EU/EEA countries reporting on the second dose. The vaccination coverage for the first dose of measles was below 95% in 12 of 27 EU/EEA countries reporting on the first dose. If the elimination goal is to be reached, the vaccination coverage rates for children targeted by routine vaccination programmes will have to be increased in a number of countries. Also, immunisation gaps need to be closed in adolescents and adults who have missed opportunities for vaccination in the past. b. Graphics Trends for ECDC measles and rubella monitoring, 2013-2016.pptx Biannual measles rubella monitoring.pdf Measles_infographic.pdf
  18. Article in Euro News: Measles is on the rise in parts of Europe amid a trend of high scepticism towards vaccines in some rich countries, research shows. According to data collected by research group Civio in partnership with Euronews, Germany alone (2,464) had four times as many incidents of the disease as the entire American continent (611) in 2015. Italy and the UK both suffered fresh outbreaks of the disease in 2016, official data shows. Europe is a world leader when it comes to lacking confidence in vaccines. Read the full article: http://www.euronews.com/2017/02/09/how-europe-s-vaccine-scepticism-is-harming-fight-to-rid-the-world-of-measles
  19. The RVC met for the fifth time on 24–26 October 2016 in Copenhagen, Denmark. The 8-member panel evaluated annual status updates for 2015 and other documentation submitted by national verification committees, now established in 51 out of 53 Member States. The RVC concluded that as of the end of 2015, endemic measles transmission was interrupted in 37 Member States, and endemic rubella transmission was interrupted in 35 Member States. Link to the page on WHO website Direct link to the report RVC page
  20. The European Regional Verification Commission for Measles and Rubella Elimination (RVC) concluded last month that 37 countries out of 53 in the European Region have demonstrated interruption of endemic transmission of measles. 35 of these countries have also demonstrated interruption of rubella. http://www.euro.who.int/en/health-topics/disease-prevention/vaccines-and-immunization/news/news/2016/11/europe-making-steady-progress-toward-measles-and-rubella-elimination More good news is the lower total numbers of cases so far in 2016 compared to previous years. Jan-Sept 2016: http://www.euro.who.int/__data/assets/pdf_file/0017/324206/EpiData-No03-2016.pdf?ua=1 Jan-Dec 2015: http://www.euro.who.int/en/health-topics/disease-prevention/vaccines-and-immunization/publications/who-epibrief-and-who-epidata/who-epidata/who-epidata,-jan.dec.-2015 Unfortunately, these tables also demonstrate that endemic circulation, or transmission after importation, will continue to be a threat wherever there are pockets of under-immunization.
  21. The 11 November 2016 issue of the WHO Weekly epidemiological record describes progress towards measles elimination in all regions of the word during 2000–2015. Annual reported measles incidence has declined by 75%, and annual estimated measles deaths by 79%, but more is needed to reach regional elimination in all but the Americas region. WER: http://apps.who.int/iris/bitstream/10665/251002/1/WER9145.pdf?ua=1 WHO news release: http://who.int/mediacentre/news/releases/2016/measles-children-death/en/ CDC: http://www.cdc.gov/mmwr/volumes/65/wr/mm6544a6.htm
  22. until
    Fifth Meeting of the European Regional Verification Commission for Measles and Rubella Elimination (RVC) 24-26 October 2016, Copenhagen, Denmark The European Regional Verification Commission for Measles and Rubella Elimination (RVC) holds annual meetings to determine the status of measles and rubella elimination in the WHO European Region based on reports and additional documents prepared and submitted by national verification committees (NVCs). Based on this review, the RVC will declare the status of the transmission and eventual achievement of elimination of measles and rubella in Member States and in the WHO European Region. The main objectives of the 2016 annual meeting will be: to inform the RVC about current epidemiology of measles and rubella in the European Region and activities of the Regional Office and the Vaccine-preventable Diseases and Immunization programme towards measles and rubella elimination, as well as global developments on measles and rubella control and elimination; to review the NVCs’ annual measles and rubella status updates for 2015, late-submitted reports for previous years and all other documentation that NVCs provide towards documenting the absence of measles and rubella endemic transmission in their countries; to define the status of transmission of measles and rubella in each Member State and in the Region in 2015; to declare the diseases’ elimination where achieved and declare the status of measles and rubella in the European Region considering the 2015 elimination targets.
×